Panadol Tablet, Film Coated
NDC Package 0135-7021-01
Package Information
Panadol (acetaminophen and diphenhydramine hcl) tablets is •do not take more than directed (see overdose warning)•adults and children 12 years of age and over: take 2 caplets at bedtime, if needed, or as directed by a doctor•do not give to children under 12 years of age. This formulation utilizes a tablet, film coated delivery system. Marketed by Haleon Us Holdings Llc, this product is identified by NDC 0135-7021 and is authorized under FDA application M013.
Identification & Billing
- RxCUI: 1092189 - acetaminophen 500 MG / diphenhydrAMINE HCl 25 MG Oral Tablet
- RxCUI: 1092189 - acetaminophen 500 MG / diphenhydramine hydrochloride 25 MG Oral Tablet
- RxCUI: 1092189 - APAP 500 MG / diphenhydramine hydrochloride 25 MG Oral Tablet
- RxCUI: 1094718 - Panadol PM EXTRA STRENGTH 500 MG / 25 MG Oral Tablet
- RxCUI: 1094718 - acetaminophen 500 MG / diphenhydramine hydrochloride 25 MG Oral Tablet [Panadol PM]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0135 - Haleon Us Holdings Llc
- 0135-7021 - Panadol
- 0135-7021-01 - 50 PACKET in 1 CARTON / 2 TABLET, FILM COATED in 1 PACKET
- 0135-7021 - Panadol
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (0135-7021). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0135-7021-01 identifies a specific commercial package of 50 packet in 1 carton / 2 tablet, film coated in 1 packet of Panadol PM, a human over the counter drug labeled by Haleon Us Holdings Llc. This tablet, film coated is formulated for oral use and contains acetaminophen; diphenhydramine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Haleon Us Holdings Llc on June 25, 2021. The current certification is valid through December 31, 2026.
How is this Haleon Us Holdings Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00135702101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.